• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

模拟 COVID-19 大规模检测的汇总样本分析策略。

Simulation of pooled-sample analysis strategies for COVID-19 mass testing.

机构信息

Heidelberg Institute of Global Health, Heidelberg University, Im Neuenheimer Feld 324, 69120, Heidelberg, Germany.

出版信息

Bull World Health Organ. 2020 Sep 1;98(9):590-598. doi: 10.2471/BLT.20.257188. Epub 2020 Jul 6.

DOI:10.2471/BLT.20.257188
PMID:33012859
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7463190/
Abstract

OBJECTIVE

To evaluate two pooled-sample analysis strategies (a routine high-throughput approach and a novel context-sensitive approach) for mass testing during the coronavirus disease 2019 (COVID-19) pandemic, with an emphasis on the number of tests required to screen a population.

METHODS

We used Monte Carlo simulations to compare the two testing strategies for different infection prevalences and pooled group sizes. With the routine high-throughput approach, heterogeneous sample pools are formed randomly for polymerase chain reaction (PCR) analysis. With the novel context-sensitive approach, PCR analysis is performed on pooled samples from homogeneous groups of similar people that have been purposively formed in the field. In both approaches, all samples contributing to pools that tested positive are subsequently analysed individually.

FINDINGS

Both pooled-sample strategies would save substantial resources compared to individual analysis during surge testing and enhanced epidemic surveillance. The context-sensitive approach offers the greatest savings: for instance, 58-89% fewer tests would be required for a pooled group size of 3 to 25 samples in a population of 150 000 with an infection prevalence of 1% or 5%. Correspondingly, the routine high-throughput strategy would require 24-80% fewer tests than individual testing.

CONCLUSION

Pooled-sample PCR screening could save resources during COVID-19 mass testing. In particular, the novel context-sensitive approach, which uses pooled samples from homogeneous population groups, could substantially reduce the number of tests required to screen a population. Pooled-sample approaches could help countries sustain population screening over extended periods of time and thereby help contain foreseeable second-wave outbreaks.

摘要

目的

评估两种合并样本分析策略(常规高通量方法和新型敏感上下文方法)在 2019 年冠状病毒病(COVID-19)大流行期间进行大规模检测的效果,重点是筛查人群所需的检测次数。

方法

我们使用蒙特卡罗模拟比较了两种不同感染率和合并组大小的检测策略。在常规高通量方法中,随机形成异质样本池进行聚合酶链反应(PCR)分析。在新型敏感上下文方法中,对在现场有意形成的同质人群的合并样本进行 PCR 分析。在这两种方法中,所有对呈阳性的池作出贡献的样本随后都进行单独分析。

发现

与个体分析相比,在激增检测和强化流行监测期间,这两种合并样本策略都将节省大量资源。敏感上下文方法提供了最大的节省:例如,在感染率为 1%或 5%的 15 万人口中,合并组大小为 3 至 25 个样本时,敏感上下文方法所需的测试次数比常规高通量策略分别减少 58-89%,而常规高通量策略则分别减少 24-80%。

结论

合并样本 PCR 筛查可在 COVID-19 大规模检测中节省资源。特别是使用同质人群的合并样本的新型敏感上下文方法,可以大大减少筛查人群所需的检测次数。合并样本方法可以帮助各国在较长时间内维持人群筛查,从而有助于遏制可预见的第二波疫情爆发。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcb6/7463190/36a5f354dfb4/BLT.20.257188-F5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcb6/7463190/d2f94f11008c/BLT.20.257188-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcb6/7463190/3de3bed9a308/BLT.20.257188-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcb6/7463190/b6ecb3cea2ea/BLT.20.257188-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcb6/7463190/6de4aabcf163/BLT.20.257188-F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcb6/7463190/36a5f354dfb4/BLT.20.257188-F5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcb6/7463190/d2f94f11008c/BLT.20.257188-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcb6/7463190/3de3bed9a308/BLT.20.257188-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcb6/7463190/b6ecb3cea2ea/BLT.20.257188-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcb6/7463190/6de4aabcf163/BLT.20.257188-F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcb6/7463190/36a5f354dfb4/BLT.20.257188-F5.jpg

相似文献

1
Simulation of pooled-sample analysis strategies for COVID-19 mass testing.模拟 COVID-19 大规模检测的汇总样本分析策略。
Bull World Health Organ. 2020 Sep 1;98(9):590-598. doi: 10.2471/BLT.20.257188. Epub 2020 Jul 6.
2
Pooled testing for COVID-19 diagnosis by real-time RT-PCR: A multi-site comparative evaluation of 5- & 10-sample pooling.实时 RT-PCR 检测 COVID-19 的混合检测:5 份和 10 份混合样本的多中心比较评估。
Indian J Med Res. 2020;152(1 & 2):88-94. doi: 10.4103/ijmr.IJMR_2304_20.
3
Large-scale implementation of pooled RNA extraction and RT-PCR for SARS-CoV-2 detection.大规模实施 RNA 提取和 RT-PCR 池检测 SARS-CoV-2。
Clin Microbiol Infect. 2020 Sep;26(9):1248-1253. doi: 10.1016/j.cmi.2020.06.009. Epub 2020 Jun 23.
4
Evaluation of pooled sample analysis strategy in expediting case detection in areas with emerging outbreaks of COVID-19: A pilot study.评估在 COVID-19 暴发地区加快病例发现的汇集样本分析策略:一项试点研究。
PLoS One. 2020 Sep 22;15(9):e0239492. doi: 10.1371/journal.pone.0239492. eCollection 2020.
5
Pooling of SARS-CoV-2 samples to increase molecular testing throughput.汇集 SARS-CoV-2 样本以提高分子检测通量。
J Clin Virol. 2020 Oct;131:104570. doi: 10.1016/j.jcv.2020.104570. Epub 2020 Aug 2.
6
Pooling for SARS-CoV-2 control in care institutions.在护理机构中对 SARS-CoV-2 进行集中控制。
BMC Infect Dis. 2020 Oct 12;20(1):745. doi: 10.1186/s12879-020-05446-0.
7
Evaluation of sample pooling for diagnosis of COVID-19 by real time-PCR: A resource-saving combat strategy.实时荧光定量 PCR 检测新冠病毒样本混合检测的评价:一种节约资源的防控策略。
J Med Virol. 2021 Mar;93(3):1526-1531. doi: 10.1002/jmv.26475. Epub 2020 Sep 29.
8
Analysis of multi-sample pools in the detection of SARS-CoV-2 RNA for mass screening: An Indian perspective.用于大规模筛查的新冠病毒RNA检测中多样本池分析:印度视角
Indian J Med Microbiol. 2020 Jul-Dec;38(3 & 4):451-456. doi: 10.4103/ijmm.IJMM_20_273.
9
Pooled Testing for Expanding COVID-19 Mass Surveillance.用于扩大新冠病毒大规模监测的混合检测
Disaster Med Public Health Prep. 2020 Jun;14(3):e42-e43. doi: 10.1017/dmp.2020.246. Epub 2020 Jul 14.
10
Proposal of RT-PCR-Based Mass Population Screening for Severe Acute Respiratory Syndrome Coronavirus 2 (Coronavirus Disease 2019).基于 RT-PCR 的严重急性呼吸综合征冠状病毒 2(COVID-19)大规模人群筛查提案。
J Mol Diagn. 2020 Oct;22(10):1294-1299. doi: 10.1016/j.jmoldx.2020.07.001. Epub 2020 Jul 30.

引用本文的文献

1
Comparison of RT-PCR cycle threshold values between individual and pooled SARS-CoV-2 infected nasopharyngeal swab specimens.个体与混合的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染的鼻咽拭子标本之间逆转录聚合酶链反应(RT-PCR)循环阈值的比较。
Narra J. 2024 Aug;4(2):e765. doi: 10.52225/narra.v4i2.765. Epub 2024 Jul 19.
2
Optimizing the detection of emerging infections using mobility-based spatial sampling.利用基于流动性的空间抽样优化新发感染的检测。
Int J Appl Earth Obs Geoinf. 2024 Jul;131:103949. doi: 10.1016/j.jag.2024.103949.
3
An integrated microfluidic platform for nucleic acid testing.

本文引用的文献

1
Large-scale implementation of pooled RNA extraction and RT-PCR for SARS-CoV-2 detection.大规模实施 RNA 提取和 RT-PCR 池检测 SARS-CoV-2。
Clin Microbiol Infect. 2020 Sep;26(9):1248-1253. doi: 10.1016/j.cmi.2020.06.009. Epub 2020 Jun 23.
2
Evaluation of COVID-19 RT-qPCR Test in Multi sample Pools.评价多份样本混合的 COVID-19 RT-qPCR 检测。
Clin Infect Dis. 2020 Nov 19;71(16):2073-2078. doi: 10.1093/cid/ciaa531.
3
COVID-19: towards controlling of a pandemic.2019冠状病毒病:迈向大流行的控制
用于核酸检测的集成微流控平台。
Microsyst Nanoeng. 2024 May 23;10:66. doi: 10.1038/s41378-024-00677-6. eCollection 2024.
4
Clinical performance of AI-integrated risk assessment pooling reveals cost savings even at high prevalence of COVID-19.人工智能集成风险评估汇集的临床性能显示,即使在 COVID-19 高流行率的情况下也能节省成本。
Sci Rep. 2024 Apr 17;14(1):8853. doi: 10.1038/s41598-024-59068-6.
5
Optimization of Screening Strategies for COVID-19: Scoping Review.COVID-19 筛查策略的优化:范围综述。
JMIR Public Health Surveill. 2024 Feb 27;10:e44349. doi: 10.2196/44349.
6
Optimizing campus-wide COVID-19 test notifications with interpretable wastewater time-series features using machine learning models.利用机器学习模型,通过可解释的污水时间序列特征优化校园范围内的 COVID-19 测试通知。
Sci Rep. 2023 Nov 24;13(1):20670. doi: 10.1038/s41598-023-47859-2.
7
Adaptive group testing strategy for infectious diseases using social contact graph partitions.利用社交接触图分区的传染病自适应分组检测策略。
Sci Rep. 2023 Jul 26;13(1):12102. doi: 10.1038/s41598-023-39326-9.
8
Comparison of Four Active SARS-CoV-2 Surveillance Strategies in Representative Population Sample Points: Two-Factor Factorial Randomized Controlled Trial.代表性人群抽样点四种主动 SARS-CoV-2 监测策略的比较:二因素析因随机对照试验。
JMIR Public Health Surveill. 2023 Aug 17;9:e44204. doi: 10.2196/44204.
9
Effectiveness of sample pooling strategies for diagnosis of SARS-CoV-2: Specimen pooling vs. RNA elutes pooling.样本混合策略用于严重急性呼吸综合征冠状病毒2诊断的有效性:样本混合与RNA洗脱液混合。
Indian J Med Microbiol. 2023 Mar-Apr;42:34-38. doi: 10.1016/j.ijmmb.2022.12.015. Epub 2023 Jan 23.
10
A statistical model for early estimation of the prevalence and severity of an epidemic or pandemic from simple tests for infection confirmation.一种通过简单的感染确认测试对传染病或大流行的流行率和严重程度进行早期估计的统计模型。
PLoS One. 2023 Jan 26;18(1):e0280874. doi: 10.1371/journal.pone.0280874. eCollection 2023.
Lancet. 2020 Mar 28;395(10229):1015-1018. doi: 10.1016/S0140-6736(20)30673-5. Epub 2020 Mar 17.
4
Public Health Measures to Slow Community Spread of Coronavirus Disease 2019.减缓2019冠状病毒病社区传播的公共卫生措施
J Infect Dis. 2020 May 11;221(11):1749-1751. doi: 10.1093/infdis/jiaa123.
5
Alert for non-respiratory symptoms of coronavirus disease 2019 patients in epidemic period: A case report of familial cluster with three asymptomatic COVID-19 patients.警惕 2019 年冠状病毒病患者在流行期间的非呼吸症状:一家三口均为无症状 COVID-19 患者的聚集性病例报告。
J Med Virol. 2021 Jan;93(1):518-521. doi: 10.1002/jmv.25776. Epub 2020 Sep 28.
6
The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application.新型冠状病毒肺炎(COVID-19)的潜伏期来自公开报告的确诊病例:估计和应用。
Ann Intern Med. 2020 May 5;172(9):577-582. doi: 10.7326/M20-0504. Epub 2020 Mar 10.
7
Looming threat of COVID-19 infection in Africa: act collectively, and fast.非洲面临新冠病毒感染的潜在威胁:迅速采取集体行动。
Lancet. 2020 Mar 14;395(10227):841-842. doi: 10.1016/S0140-6736(20)30464-5. Epub 2020 Feb 27.
8
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
9
COVID-19 control in China during mass population movements at New Year.新年期间中国大规模人口流动情况下的新冠疫情防控
Lancet. 2020 Mar 7;395(10226):764-766. doi: 10.1016/S0140-6736(20)30421-9. Epub 2020 Feb 24.
10
Preparedness and vulnerability of African countries against importations of COVID-19: a modelling study.非洲国家防范 COVID-19 输入的准备情况和脆弱性:建模研究。
Lancet. 2020 Mar 14;395(10227):871-877. doi: 10.1016/S0140-6736(20)30411-6. Epub 2020 Feb 20.